UAE-based longevity healthtech company Longevium has raised $7 million in its first funding round to establish an AI-powered Longevity Research Laboratory at Dubai Science Park, led by founder Dr Ksenia Butova. The facility is expected to open in Q4 2026 and will focus on research and development rather than clinical services.
The laboratory will combine artificial intelligence, biomedical research, and clinical science to develop technologies that predict health risks, measure biological ageing, and support healthier lifespans.
Research will cover AI-powered digital twins, regenerative medicine, tissue engineering, advanced cell therapies, robotic diagnostics, smart medical devices, and noble gas therapies.
The funding will be used to build the laboratory and expand research into next-generation diagnostics, longevity technologies, and clinical research programmes, supporting Dubai's ambition to become a global hub for longevity medicine.
Press release:
